Compass Financial Management »

Northwest Biotherapeutics In shares owned by Compass Financial Management

Quarter-by-quarter ownership of Northwest Biotherapeutics In (NWBO) shares owned by Compass Financial Management from 13F filings

Historical chart of Compass Financial Management investment in Northwest Biotherapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Northwest Biotherapeutics In held by Compass Financial Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Northwest Biotherapeutics In by Compass Financial Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $227k 1.2M 0.19

More positions owned by Compass Financial Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Technology SPDR (XLK)
Spdr S&p 500 Etf (SPY)
Janus Detroit Str Tr (JAAA)
Invesco Qqq Trust Series 1 (QQQ)
Palantir Technologies Inclass A Com Cl A (PLTR)
SPDR DJ Wilshire Large Cap Growth (SPYG)
Vanguard S&p 500 Etf idx (VOO)
Amazon (AMZN)
Alphabet Inc Class A Com Cl A (GOOGL)
Alphabet Inc Class C Com Cl C (GOOG)
Vanguard High Dividend Yield ETF (VYM)
Meta Platforms Inc Class A Com Cl A (META)

View all positions for Compass Financial Management

Top funds holding Northwest Biotherapeutics In

Compass Financial Management
Wall Street Access Asset Management
VSM Wealth Advisory
Opus Capital Group
Ethos Financial Group
Williams Jones Wealth Management
Coston, McIsaac & Partners
McIlrath & Eck
Hantz Financial Services

View all funds holding Northwest Biotherapeutics In